Current Parkinson’s disease drugs improve the motor symptoms without influencing the underlying pathology or the natural history. Serendipitous research identified disease modifying properties for Parkinson’s disease in drugs prescribed for unrelated conditions. This has led to detailed studies of animal models, retrospective analyses of large clinical databases, and some clinical trials, to investigate their future potential.
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.